يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Jonathan Mauer"', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health Benefits

    المؤلفون: Kevin Marsh, Hannah Collacott, Jim Thomson, Jonathan Mauer, Stephen Watt, Koonal Shah, Brett Hauber, Louis Garrison, Mendwas Dzingina

    المصدر: Springer;International Academy of Health Preference Research, The Patient: Patient-Centered Outcomes Research. 17(3):229-237

    الإتاحة: https://ideas.repec.org/a/spr/patien/v17y2024i3d10.1007_s40271-024-00676-9.html

    أضف إلى المفضلة
  2. 2
    Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis

    المؤلفون: Jonathan Mauer, Kristin Bullok, Stephen Watt, Ed Whalen, Leo Russo, Rod Junor, John Markman, Brett Hauber, Tommi Tervonen

    المصدر: British journal of clinical pharmacology. 88(8)

    مصطلحات موضوعية: Pharmacology, Celecoxib, Anti-Inflammatory Agents, Non-Steroidal, Osteoarthritis, Humans, Pharmacology (medical), Opioid-Related Disorders, Risk Assessment, Randomized Controlled Trials as Topic

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b24e0a7847dd8681317f2f557ac6334c
    https://pubmed.ncbi.nlm.nih.gov/35277997

    View record at Wiley
    أضف إلى المفضلة
  3. 3
    An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?

    المؤلفون: Richard C. Hermann, Cathy Anne Pinto, Isabelle Huys, Karin Schölin Bywall, Eline van Overbeeke, Esther W. de Bekker-Grob, Jonathan Mauer, Chiara Whichello, Irina Cleemput, Jorien Veldwijk, Watt Stephen

    المساهمون: Health Technology Assessment (HTA)

    المصدر: Health Policy. Elsevier Ireland Ltd
    Health Policy

    مصطلحات موضوعية: INVOLVEMENT, Medical Ethics, Technology Assessment, Biomedical, Process management, Decision Making, Social and Clinical Pharmacy, Regulatory decision-making, Medicinsk etik, 03 medical and health sciences, 0302 clinical medicine, Health care, Humans, 030212 general & internal medicine, Decision-making, Reimbursement, Science & Technology, Decision-Making, business.industry, 030503 health policy & services, Health Policy, Samhällsfarmaci och klinisk farmaci, Stakeholder, HTA decision-making, Patient Preference, Patient preferences, Patient preference information, FRAMEWORK, Patient preference, Europe, Health Care Sciences & Services, Medical product, Order (business), Health Policy & Services, Industry decision-making, 0305 other medical science, business, Know-how, Life Sciences & Biomedicine, HEALTH TECHNOLOGY-ASSESSMENT

    وصف الملف: application/pdf; Print-Electronic

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62cf3454141c5c57b072bcf9a01bd2d2
    http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-417785

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  4. 4
    PMU100 - MAPPING BENEFIT-RISK DECISION-MAKING PROCESSES AND IDENTIFYING DECISION POINTS WITH THE POTENTIAL TO INCLUDE PATIENT PREFERENCE INFORMATION THROUGHOUT THE MEDICAL PRODUCT LIFECYCLE

    المؤلفون: Jorien Veldwijk, Isabelle Huys, K Schölin Bywall, Chiara Whichello, S Watt, Richard C. Hermann, Cathy Anne Pinto, E.W. de Bekker-Grob, Jonathan Mauer, Irina Cleemput, E. van Overbeeke

    المصدر: Value in Health. 21:S324

    مصطلحات موضوعية: Decision points, Business economics, Process management, Medical product, Health Policy, Public Health, Environmental and Occupational Health, Business, Patient preference

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f1e49646085a11e0a82c43e852708bf8
    https://doi.org/10.1016/j.jval.2018.09.1936

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء